Results 231 to 240 of about 496,828 (359)

Thorn-shaped astrocytes in the depth of cortical sulci in Western Pacific ALS/Parkinsonism-Dementia complex

, 2020
Gábor G. Kovács, John Robinson, Daniel P. Perl, Virginia M.‐Y. Lee, John Q. Trojanowski   +4 more
openalex   +2 more sources

Engineering Neuronal Network Connectivity Through Precise and Scalable Electrical Modulation

Advanced Science, EarlyView.
This study presents a scalable all‐electrical method for precise neuronal‐circuit reconfiguration based on high‐density microelectrode arrays. By employing biologically inspired plasticity rules, targeted connectivity changes were successfully induced and quantified across diverse neuronal preparations.
Sreedhar S. Kumar, Yannaël Bossard, Rachel Sava, Tobias Gänswein, Lorenca Sadiraj, Jean‐Samuel Dupré, Manuel Schröter, J. Gray Camp, Fernando Cardes, Julian Bartram, Andreas Hierlemann   +10 more
wiley   +1 more source

Tetrahidrocanabinol e Canabidiol no tratamento da Doença de Parkinson, há evidência? Uma revisão integrativa

Daniel Antunes Pereira, Shara Aline Bueno Dantas, Yasmin Faria Menezes Castro Santos, Sonia Alexandra Hernandez   +3 more
openalex   +2 more sources

Mobile applications dealing with Parkinson�s disease: A systematic review (Preprint)

, 2017
Sonia Estevez-Martin, M. Emilia Cambronero, Yolanda García-Ruiz, Luis Llana   +3 more
openalex   +1 more source

Chronic Disease Monitoring Using Advanced Compliant Materials for Bioelectronics

Advanced Electronic Materials, EarlyView.
Compliant bioelectronic systems enable continuous monitoring of chronic disease through soft, stretchable materials and tissue‐conformal designs that support stable electrophysiological, mechanical, and biochemical sensing. Integration of diverse sensing modalities with thoughtful material selection, device architectures, and advanced fabrication ...
Han Kim, Mabel Bartlett, Liyang Wang, Karl Bates, Mengdi He, Myungbo Kim, Carmel Majidi, Tzahi Cohen‐Karni   +7 more
wiley   +1 more source

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial.

JAMA Neurol
Fernandez HH, Isaacson SH, Hauser RA, Agarwal P, Ondo W, Park A, Kremens D, Leoni M, Duvvuri S, Combs C, Koenig E, Chang I, Pastino G, Tringali S, Golonski N, Sanchez R, Harmer L, Boiser J, Zadikoff C, Mari Z.   +19 more
europepmc   +1 more source

Investigating the Genetic Relationship Between Vitamin B12 Metabolism and Parkinson Disease. [PDF]

Neurol Genet
Dering R, Onvumere M, Liu L, Huot P, Gan-Or Z, Senkevich K.   +5 more
europepmc   +1 more source

Non-Motor Features of Parkinson Disease: A New Clinical State of The Art

Isadora Vergamini Lamana, Ana Carolina Gomes de Oliveira, Larissa Tarraf Bertazzo, Natália Balbo Arantes Nogueira, Júlio César Claudino dos Santos, Luana Stangherlin   +5 more
openalex   +2 more sources

Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models

AGING MEDICINE, EarlyView.
CB1 receptor (CB1R) expression was significantly reduced in the hippocampus, medial frontal gyrus, and superior temporal gyrus of Alzheimer's patients. CB1R levels negatively correlated with amyloid‐β and tau pathology. In addition, CB1R expression was also reduced in the cortex of 5xFAD mice and in the hippocampus of Tg4‐42 mice.
Nike von Borcke, Amrei Vivian Purwien, Annik Steiert, Henrike Hasecke, Yvonne Bouter   +4 more
wiley   +1 more source

Correction: Metabolic modeling of microbial communities in the chicken ceca reveals a landscape of competition and co-operation. [PDF]

Microbiome
Utkina I, Fan Y, Willing BP, Parkinson J.   +3 more
europepmc   +1 more source